MoscowThe century-old tuberculosis vaccine fails adults.
Russia’s Gamaleya Institute says GamTBvac will finish trials by end-2026 and register in 2027, Health Minister Irina Vasilyeva confirmed.
No peer-reviewed efficacy data has been published; Russia targets Africa and Southeast Asia after registration.
Sources: TASS